To find the best approach for you, we help you identify your personal needs, goals, and challenges and build a personalized plan for success
Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials
View All Products Compare GLP-1 Peptides Product Specifications Research-grade, manufacturer-verified Lyophilised powder ~4.4 kDa -20C (lyophilised), 2-8C (reconstituted) Bacteriostatic water or sterile saline 39-residue triple agonist (GLP-1 / GIP / Glucagon) Aib substitutions C20 fatty-diacid acylation Research Use Only: These products are intended for laboratory research use only and are not approved for human consumption
It is important not to administer Byetta after a meal, as this reduces its effectiveness
However, if you regain weight after stopping Ozempic, some of that weight will return to your face, reducing the appearance of Ozempic face